DE602004018547D1 - Herstellung von tacrolimus (fk-506) unter verwendung neuer streptomyces-spezies - Google Patents

Herstellung von tacrolimus (fk-506) unter verwendung neuer streptomyces-spezies

Info

Publication number
DE602004018547D1
DE602004018547D1 DE602004018547T DE602004018547T DE602004018547D1 DE 602004018547 D1 DE602004018547 D1 DE 602004018547D1 DE 602004018547 T DE602004018547 T DE 602004018547T DE 602004018547 T DE602004018547 T DE 602004018547T DE 602004018547 D1 DE602004018547 D1 DE 602004018547D1
Authority
DE
Germany
Prior art keywords
tacrolimus
preparation
streptomyces species
new streptomyces
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602004018547T
Other languages
English (en)
Inventor
Parveen Kumar
Sunita Sharma
Aniruddha Shukla
Sudeep Kumar
Raj Kumar Maurya
Vikas Katial
Ashoke Mitra
P Shri Jagdish Gigras
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of DE602004018547D1 publication Critical patent/DE602004018547D1/de
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE602004018547T 2003-10-17 2004-10-15 Herstellung von tacrolimus (fk-506) unter verwendung neuer streptomyces-spezies Expired - Fee Related DE602004018547D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1284DE2003 2003-10-17
PCT/IB2004/003380 WO2005038009A2 (en) 2003-10-17 2004-10-15 Production of tacrolimus (fk-506) using new streptomyces species

Publications (1)

Publication Number Publication Date
DE602004018547D1 true DE602004018547D1 (de) 2009-01-29

Family

ID=34452218

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004018547T Expired - Fee Related DE602004018547D1 (de) 2003-10-17 2004-10-15 Herstellung von tacrolimus (fk-506) unter verwendung neuer streptomyces-spezies

Country Status (7)

Country Link
US (1) US20070191415A1 (de)
EP (1) EP1751272B8 (de)
CN (1) CN1867664A (de)
AT (1) ATE417921T1 (de)
DE (1) DE602004018547D1 (de)
ES (1) ES2317066T3 (de)
WO (1) WO2005038009A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100448984C (zh) * 2006-03-07 2009-01-07 广东省微生物研究所 粤蓝链霉菌
US7744717B2 (en) 2006-07-17 2010-06-29 E. I. Du Pont De Nemours And Company Process for enhancing the resolution of a thermally transferred pattern
CN101486975B (zh) * 2008-01-18 2012-04-18 浙江海正药业股份有限公司 一种链霉菌、用其产生他克莫司的方法及其应用
EP2272963A1 (de) 2009-07-09 2011-01-12 LEK Pharmaceuticals d.d. Verfahren zur Herstellung von Tacrolimus
KR101261131B1 (ko) 2010-08-24 2013-05-06 이화여자대학교 산학협력단 신규 타크롤리무스 유도체, 상기 유도체를 포함하는 신경 보호용 조성물, 상기 유도체를 포함하는 면역 억제용 조성물, 상기 유도체의 생산 방법 및 상기 유도체의 생산 균주
WO2012026665A1 (en) * 2010-08-24 2012-03-01 Ewha University - Industry Collaboration Foundation Novel tacrolimus derivatives, a neuroprotective composition comprising the same, an immunosuppressive composition comprising the same, a method for preparing the same, and a mutant for producing the same
RU2495937C1 (ru) * 2012-04-02 2013-10-20 Общество с ограниченной ответственностью "Фарминс"/Pharmins Ltd. (ООО "Фарминс"/Pharmins Ltd.) Способ получения такролимуса методом микробиологического синтеза
CN117088931A (zh) 2014-08-12 2023-11-21 莫纳什大学 定向淋巴的前药
KR101729251B1 (ko) 2015-04-28 2017-04-21 주식회사 대웅 보툴리눔 독소의 제조를 위한 배지 조성물
WO2017041139A1 (en) 2015-09-08 2017-03-16 Monash University Lymph directing prodrugs
CN108384819B (zh) * 2017-02-03 2021-06-25 上海医药工业研究院 一种用于发酵他克莫司的培养基以及发酵方法
US11883497B2 (en) 2017-08-29 2024-01-30 Puretech Lyt, Inc. Lymphatic system-directing lipid prodrugs
US11304954B2 (en) 2017-12-19 2022-04-19 Puretech Lyt, Inc. Lipid prodrugs of mycophenolic acid and uses thereof
WO2019126374A1 (en) * 2017-12-19 2019-06-27 Ariya Therapeutics, Inc. Lipid prodrugs of rapamycin and its analogs and uses thereof
US11608345B1 (en) 2017-12-19 2023-03-21 Puretech Lyt, Inc. Lipid prodrugs of rapamycin and its analogs and uses thereof
CN108929335B (zh) * 2018-08-31 2021-07-20 福建省微生物研究所 一种他克莫司粗晶的制备方法
CA3166908A1 (en) 2020-02-05 2021-08-12 Daniel Kenneth BONNER Lipid prodrugs of neurosteroids
CN112159826B (zh) * 2020-09-14 2022-05-24 浙江工业大学 一种提高他克莫司产量的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4137126A (en) * 1975-05-03 1979-01-30 Givaudan Corporation Process for preparing glucose isomerase using streptomyces glaucescens mutants
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
US5116756A (en) * 1991-01-28 1992-05-26 Merck & Co., Inc. Process for producing FK-506
US5194378A (en) * 1991-01-28 1993-03-16 Merck & Co., Inc. Process for producing fk-506
US5264355A (en) * 1992-07-02 1993-11-23 Merck & Co., Inc. Methlating enzyme from streptomyces MA6858

Also Published As

Publication number Publication date
EP1751272B8 (de) 2009-04-15
US20070191415A1 (en) 2007-08-16
WO2005038009A3 (en) 2005-06-16
WO2005038009A2 (en) 2005-04-28
EP1751272A2 (de) 2007-02-14
CN1867664A (zh) 2006-11-22
ES2317066T3 (es) 2009-04-16
ATE417921T1 (de) 2009-01-15
EP1751272B1 (de) 2008-12-17

Similar Documents

Publication Publication Date Title
DE602004018547D1 (de) Herstellung von tacrolimus (fk-506) unter verwendung neuer streptomyces-spezies
CO5700767A2 (es) Procedimiento de tratamiento de rechazo de transplantes
DE60235928D1 (de) Mittel zur Suppression von Transplantat-Abstossung
MXPA02007137A (es) Fuente de tejido hepatico.
WO2004101758A3 (en) Composition for maintaining organ and cell viability
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
CY1116107T1 (el) Ενωσεις για χρηση στην αγωγη αυτοανοσων παθησεων, ανοσο-αλλεργικων παθησεων και απορριψης μεταμοσχευσης οργανων ή ιστων
ATE382681T1 (de) Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen
EP2402325A3 (de) Hydroxylierte und methoxylierte Cyclopenta[d]pyrimidine als AKT-Proteinkinase-Inhibitoren
WO2002069949A3 (en) Combination therapy for reduction of toxycity of chemotherapeutic agents
DE602005026866D1 (de) Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
WO2004039248A3 (en) Repairing or replacing tissues or organs
MXPA05007462A (es) Derivados de pirrolopiridazina.
NO20074723L (no) Farmasoytisk sammensetning og fremgangsmate for anvendelse av antisoppmiddel i kombinasjon
FR2882751B1 (fr) Hydrazinocarbonyl-thieno[2,3-c]pyrazoles, procede de preparation, compositions les contenant et utilisation
WO2005042060A3 (en) Method and composition comprising pyruvate, inosine, adenine, phosphate and an aziridino compound for treating a biological sample
WO2005089294A3 (en) Synthesis of indenoisoquinoliniums and methods of use
ATE475408T1 (de) Formulierungen von tipifarnib zur intravenösen verabreichung
BR9612821A (pt) Métodos para a prevenção de rejeição de enxerto em transplante e para a produção de uma célula de hospedeiro para terapia genética universal
EP1599128A4 (de) Verfahren zur behandlung von erkrankungen durch transplantation von entwickelnden allogenen oder xenogenen organen oder geweben
WO2004073375A8 (en) Podophyllotoxin derivatives as antitumor agents
ATE335475T1 (de) Verwendung von beschleunigten lymphozyten zielansteuernden wirkstoffen zur herstellung eines medikaments für die behandlung der verzögertern transplantat-funktion
WO2005009333A3 (en) Combined treatments comprising synthetic peptide copolymers for preventing graft rejection
WO2005060349A3 (en) Compositions derived from portulaca oleracea l. and methods of using same for modulating blood glucose levels
WO2005018540A3 (en) Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee